It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2010.
2010 | Bangalore, Karnataka, India | ActiveCito Remedies Private Limited, a active private limited company, was established on 07 June 2010 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909KA2010PTC053969. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.60 M.
It upholds a compliant status. Its leadership includes Mysore Sreekantiah Shivani (Director), Umadevi Puttaswamygowda Daniharry (Director), Shravanabelagola Nanjundaiah Sreekantaiah (Director). Past directors included Umadevi Puttaswamygowda Daniharry. It holds ₹2.40 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 167/F 1, 2Nd Cross, Canara Bank Colony, Nagarabhavi, Bangalore South, Bangalore, Karnataka, 560072.
U51909KA2010PTC053969
053969
07 June 2010
₹1.00 M
₹0.60 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Cito Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mysore Sreekantiah Shivani | Director | 07 Jun 2010 | Current |
| Umadevi Puttaswamygowda Daniharry | Director | 14 Jun 2019 | Current |
| Shravanabelagola Nanjundaiah Sreekantaiah | Director | 07 Jun 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cito Remedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 50.15% increase. The company also saw a substantial fall in profitability, with a 10.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Cito Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 2010 | State Bank Of India | ₹2.40 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cito Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cito Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cito Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cito Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Cito Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Umadevi Puttaswamygowda Daniharry was appointed as a Director was appointed as a Director on 14 Jun 2019 & has been associated with this company since 6 years 5 months . was documented.
The activity A charge with State Bank Of India amounted to Rs. 2.40 M with Charge ID 10250628 was registered on 06 Oct 2010. was completed.
Progress on Mysore Sreekantiah Shivani was appointed as a Director was appointed as a Director on 07 Jun 2010 & has been associated with this company since 15 years 5 months . was documented.
Progress on Shravanabelagola Nanjundaiah Sreekantaiah was appointed as a Director was appointed as a Director on 07 Jun 2010 & has been associated with this company since 15 years 5 months . was documented.
The CIN of Cito Remedies Private Limited is U51909KA2010PTC053969.
Cito Remedies Private Limited is headquartered at 167/F 1, 2Nd Cross, Canara Bank Colony, Nagarabhavi, Bangalore South, Bangalore, Karnataka, 560072.
Cito Remedies Private Limited was incorporated on 07 June 2010.
The current directors of Cito Remedies Private Limited are
The primary industry of Cito Remedies Private Limited is Pharma.
Cito Remedies Private Limited is unlisted.
The authorized capital of Cito Remedies Private Limited is ₹1.00 M, and the paid-up capital is ₹0.60 M.
The compliance status of Cito Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX